The Basophil Activation Test (BAT), which evaluates an allergen’s capacity to induce clinical symptoms of allergy by cross-linking specific IgE, which transduces a signal into the cell with the outcome of releasing of preformed mediators, is a promising adjunctive diagnostic tool, particularly in cases where traditional testing yields inconclusive results [125]. This evidence concerns the gene IGHE and allergic disease.